MedTrace Logo

Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody

NCT00304408 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2010-09-10

No results posted yet for this study

Summary

The purpose of this study is three fold: 1)To collect serum from patients with documented Clostridium difficile infection and test for the presence of antibody to C. difficile toxin at the start and at the end of therapy, and again if a relapse or recurrence occurs. 2)To collect stool samples for test of C. difficile toxin at similar time intervals. 3)To assay random serum samples from the VA lab in order to determine the rate of antibody to C. difficile toxin in our patient population.

Conditions

  • Clostridium Enterocolitis
  • Pseudomembranous Colitis
  • Antibiotic-Associated Colitis

Sponsors & Collaborators

  • Baylor College of Medicine

    collaborator OTHER

  • Michael E. DeBakey VA Medical Center

    lead FED

Principal Investigators

  • Daniel M Musher, M.D. · Michael E. DeBakey VA Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00304408 on ClinicalTrials.gov